JP2020524509A5 - - Google Patents

Download PDF

Info

Publication number
JP2020524509A5
JP2020524509A5 JP2019570475A JP2019570475A JP2020524509A5 JP 2020524509 A5 JP2020524509 A5 JP 2020524509A5 JP 2019570475 A JP2019570475 A JP 2019570475A JP 2019570475 A JP2019570475 A JP 2019570475A JP 2020524509 A5 JP2020524509 A5 JP 2020524509A5
Authority
JP
Japan
Prior art keywords
nos
seq
determining
sample
mirna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019570475A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020524509A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/036377 external-priority patent/WO2018236589A1/en
Publication of JP2020524509A publication Critical patent/JP2020524509A/ja
Publication of JP2020524509A5 publication Critical patent/JP2020524509A5/ja
Pending legal-status Critical Current

Links

JP2019570475A 2017-06-19 2018-06-07 アルツハイマー病の診断のための循環血清マイクロｒｎａバイオマーカー及び方法 Pending JP2020524509A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762521768P 2017-06-19 2017-06-19
US62/521,768 2017-06-19
PCT/US2018/036377 WO2018236589A1 (en) 2017-06-19 2018-06-07 Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis

Publications (2)

Publication Number Publication Date
JP2020524509A JP2020524509A (ja) 2020-08-20
JP2020524509A5 true JP2020524509A5 (enExample) 2021-07-29

Family

ID=62952378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019570475A Pending JP2020524509A (ja) 2017-06-19 2018-06-07 アルツハイマー病の診断のための循環血清マイクロｒｎａバイオマーカー及び方法

Country Status (5)

Country Link
US (2) US11634775B2 (enExample)
EP (2) EP3642366B1 (enExample)
JP (1) JP2020524509A (enExample)
ES (1) ES2965473T3 (enExample)
WO (1) WO2018236589A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3069445A1 (en) * 2017-07-12 2019-01-17 P. Hemachandra REDDY Microrna-455-3p as a peripheral biomarker for alzheimer's disease
CN111073973A (zh) * 2019-12-10 2020-04-28 石河子大学 一种用于早期诊断2型糖尿病的microRNA序列及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009457A1 (en) * 2007-07-06 2009-01-15 University Of Louisville Research Foundation, Inc. Alzheimer's disease-specific micro-rna microarray and related methods
US20120108650A1 (en) * 2010-10-29 2012-05-03 Emory University Micro rna markers and methods related thereto
US9771617B2 (en) 2011-06-27 2017-09-26 Eisai R&D Management Co., Ltd. Microrna biomarkers indicative of alzheimer's disease
EP2742155B1 (en) 2011-08-08 2018-01-24 Advanced Genomic Technology LLC Biomarker for alzheimer's disease and/or mild cognitively impairment
US20140206777A1 (en) 2011-08-16 2014-07-24 Rosetta Genomics Ltd. Methods and compositions for diagnosis of alzheimer's disease
EP3071712B1 (en) 2013-11-18 2020-06-24 DiamiR, LLC Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd)
WO2015179909A1 (en) * 2014-05-26 2015-12-03 The University Of Melbourne Mirna biomarkers of alzheimer's disease
US10738360B2 (en) 2015-03-13 2020-08-11 Hiroshima University Method for assisting detection of alzheimer'S disease or mild cognitive impairment
JP7197755B2 (ja) * 2016-02-05 2022-12-28 セント・ジョーンズ・ユニバーシティ 循環血清マイクロｒｎａバイオマーカー及び方法
WO2017165458A1 (en) * 2016-03-21 2017-09-28 Diamir, Llc Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
Labeau et al. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome
Selman et al. Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing
Zhang et al. Long noncoding RNA Cfast regulates cardiac fibrosis
WO2010023327A4 (en) Method for obtaining oligonucleotide aptamers and uses thereof
Zhou et al. Circulating exosomal microRNAs as emerging non‐invasive clinical biomarkers in heart failure: mega bio‐roles of a nano bio‐particle
JP2019506183A5 (enExample)
Viemann et al. H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response
JP2010528659A (ja) 肝細胞癌のサブタイプを決定し、肝癌幹細胞を検出するための方法
JP2014532428A5 (enExample)
Morán et al. Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection
Konstantinell et al. MicroRNAs as potential biomarkers in Merkel cell carcinoma
Brogaard et al. Late regulation of immune genes and microRNAs in circulating leukocytes in a pig model of influenza A (H1N2) infection
JP6923215B2 (ja) 抗ｈｔｌｖ−１剤、ｈｔｌｖ−１関連脊髄症（ｈａｍ／ｔｓｐ）治療薬
Pitolli et al. Non-canonical splicing and its implications in brain physiology and cancer
Reza Etemadi et al. Gene expression patterns induced at different stages of rhinovirus infection in human alveolar epithelial cells
Xu et al. Circular RNA CircCDKN2B− AS_006 Promotes the tumor-like growth and metastasis of rheumatoid arthritis synovial fibroblasts by targeting the miR− 1258/RUNX1 axis
JP2020524509A5 (enExample)
CN111214663A (zh) Tmed2在作为埃博拉病毒病治疗靶点中的应用
Jang et al. Molecular responses to the influenza A virus in chicken trachea-derived cells
Kim et al. An infectious cDNA clone of a growth attenuated Korean isolate of MERS coronavirus KNIH002 in clade B
WO2009116860A1 (en) Markers providing prognosis of metastasis among cancer patients
WO2015085904A1 (zh) 禽流感病毒miRNA及其鉴定、检测和应用
JP2013526869A5 (enExample)
JP2013521497A5 (enExample)
Tan et al. Long noncoding RNA-dependent regulation of vascular smooth muscle cell proliferation and migration in hypertension